CArdioSurgEry Atrial Fibrillation Register

CArdioSurgEry Atrial Fibrillation Register - CASE-AF Register

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03091452

Acronym

CASE-AF

Enrollment

2000

Registered

2017-03-27

Start date

2017-01-31

Completion date

2029-12-31

Last updated

2025-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation.

Detailed description

CASE AF aims to describe the reality of medical care of patients in whom atrial fibrillation is treated by cardiac surgical ablation. In particular, the following questions should be answered: * Indication: Which are the different indications for cardiac surgical ablation in patients with atrial fibrillation? * How often and in which patients the different concepts of surgery and ablation procedures are used? At the same time, how often an intervention at the left atrial appendage is carried out? * Safety: How secure is the cardiac surgical ablation of atrial fibrillation (periprocedural, during hospital stay and during the long-term follow up)? * Effectiveness: How effectively is the cardiac surgical ablation of atrial fibrillation (procedural success)? How often are AF recurrences in the long-term follow up? * What is the concommitant medical treatment after surgical ablation?

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 100 Years

Healthy volunteers

Inclusion criteria

* Atrial fibrilation * Treated by cardiac surgical ablation

Exclusion criteria

* Patient denies participation

Design outcomes

Primary

Measure	Time frame	Description
Number of major bleeding events	12 months	Documentation of procedural results and clinical short-and long-term results of the documented therapies

Secondary

Measure	Time frame	Description
Number of major adverse cardiac events	12 months	Documentation of procedural results and clinical short-and long-term results of the documented therapies
Complications during hospital stay	12 months	Documentation of hospital mortality, nonfatal major complications

Countries

Germany

Contacts

Primary ContactBelgin Özdemir

oezdemir@stiftung-ihf.de00496215032888

Outcome results